Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018.
作者信息
Rhee Taeho Greg, Maust Donovan T, Fiellin David A, Olfson Mark
机构信息
Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, Connecticut; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
出版信息
Am J Prev Med. 2021 Mar;60(3):434-437. doi: 10.1016/j.amepre.2020.09.007. Epub 2020 Nov 13.
Abstract
摘要
相似文献
1
Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018.2007 - 2018年美国成年人中阿片类药物与阿片类药物增效剂联合处方的趋势
Am J Prev Med. 2021 Mar;60(3):434-437. doi: 10.1016/j.amepre.2020.09.007. Epub 2020 Nov 13.
2
Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012-2019.美国普通牙医和口腔专家在 2012-2019 年的阿片类药物处方趋势。
Am J Prev Med. 2022 Jul;63(1):3-12. doi: 10.1016/j.amepre.2022.01.009. Epub 2022 Feb 26.
3
Opioid Prescribing Patterns of Optometrists in the Medicare Part D Database.在 Medicare Part D 数据库中视光师的阿片类药物处方模式。
Optom Vis Sci. 2022 Jan 1;99(1):31-34. doi: 10.1097/OPX.0000000000001827.
4
Survey of Ontario primary care physicians' experiences with opioid prescribing.安大略省初级保健医生阿片类药物处方经验调查。
Can Fam Physician. 2011 Mar;57(3):324-32.
5
State variation in opioid and benzodiazepine prescriptions between independent and nonindependent advanced practice registered nurse prescribing states.独立与非独立高级执业注册护士开处方州之间阿片类药物和苯二氮䓬类药物处方的州差异。
Nurs Outlook. 2016 Jan-Feb;64(1):86-93. doi: 10.1016/j.outlook.2015.10.003. Epub 2015 Oct 22.
6
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统，八个州，2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
7
Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012-2017.2012-2017 年美国商业保险患者初始阿片类药物处方情况。
N Engl J Med. 2019 Mar 14;380(11):1043-1052. doi: 10.1056/NEJMsa1807069.
8
Children Are Not Little Adults When Prescribing Opioids.
JAMA Surg. 2021 Jan 1;156(1):91. doi: 10.1001/jamasurg.2020.5150.
9
Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.
Ann Intern Med. 2022 Oct;175(10):W118. doi: 10.7326/L22-0247.
10
[Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].[贝鲁特法国主宫医院阿片类镇痛药的处方模式]
Encephale. 2016 Dec;42(6):511-516. doi: 10.1016/j.encep.2016.05.010. Epub 2016 Oct 21.
引用本文的文献
1
Cohort study of new off-label gabapentin prescribing in chronic opioid users.慢性阿片类药物使用者新的加巴喷丁超说明书用药队列研究。
Reg Anesth Pain Med. 2024 Feb 5;49(2):88-93. doi: 10.1136/rapm-2023-104613.
2
Pain Management in Older Adults Before and During the First Year of COVID-19 Pandemic: Prevalence, Trends, and Correlates.老年人在 COVID-19 大流行前和大流行期间的疼痛管理：流行率、趋势和相关因素。
J Gerontol A Biol Sci Med Sci. 2023 Aug 27;78(9):1627-1640. doi: 10.1093/gerona/glad115.
3
Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018.2014 - 2018年美国中重度疼痛成人使用非阿片类止痛药物的处方趋势
J Pain. 2022 Jul;23(7):1187-1195. doi: 10.1016/j.jpain.2022.01.006. Epub 2022 Feb 8.
4
Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare.在参加联邦医疗保险优势计划和传统联邦医疗保险的老年人群中，阿片类药物和中枢神经系统抑制剂类药物的处方开具情况。
Am J Geriatr Psychiatry. 2022 Feb;30(2):249-255. doi: 10.1016/j.jagp.2021.08.010. Epub 2021 Aug 28.
5
New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery.接受乳房切除术和重建手术的患者中新出现和持续的阿片类物质滥用。
Breast Cancer Res Treat. 2021 Sep;189(2):445-454. doi: 10.1007/s10549-021-06275-8. Epub 2021 Jun 4.
本文引用的文献
1
Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016.2009-2016 年美国商业保险成年人群中加巴喷丁处方趋势。
J Manag Care Spec Pharm. 2020 Mar;26(3):246-252. doi: 10.18553/jmcp.2020.26.3.246.
2
Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.美国食品药品监督管理局发布警示前后阿片类药物与苯二氮䓬类药物联合使用情况
JAMA Psychiatry. 2019 Nov 1;76(11):1208-1210. doi: 10.1001/jamapsychiatry.2019.2563.
3
Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017.2013年至2017年医疗保险对阿片类增效剂的处方集覆盖范围及限制
J Gen Intern Med. 2019 Apr;34(4):518-520. doi: 10.1007/s11606-018-4752-8.
4
Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.老年人苯二氮䓬类和阿片类药物的联合处方：比率、相关性和国家趋势。
J Gerontol A Biol Sci Med Sci. 2019 Nov 13;74(12):1910-1915. doi: 10.1093/gerona/gly283.
5
Food and Drug Administration Requires Strong Warnings for Opioid Analgesics, Prescription Opioid Cough Products, and Benzodiazepine Labeling Related to Serious Risks and Death From Combined Use.美国食品药品监督管理局要求对阿片类镇痛药、处方阿片类止咳产品以及与联合使用相关的严重风险和死亡的苯二氮䓬类药物标签添加强烈警告。
J Pain Palliat Care Pharmacother. 2016 Dec;30(4):298-299. doi: 10.1080/15360288.2016.1241336.
6
Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.2002 - 2014年阿片类药物与苯二氮䓬类药物联合处方趋势
Am J Prev Med. 2016 Aug;51(2):151-160. doi: 10.1016/j.amepre.2016.02.014. Epub 2016 Apr 11.
Zotero 插件